Literature DB >> 11983833

Characterization of diet-dependent metabolic serotypes: proof of principle in female and male rats.

Honglian Shi1, Karen E Vigneau-Callahan, Alexander I Shestopalov, Paul E Milbury, Wayne R Matson, Bruce S Kristal.   

Abstract

Our research seeks to identify a serum profile, or serotype, that reflects substantial changes in food intake. Earlier studies demonstrated that a number of low-molecular-weight, redox-active compounds of metabolome were sufficiently stable analytically and biologically to identify biomarkers of dietary restriction (DR, restriction of total food intake) in rats. A second initial requirement is to demonstrate feasibility, i.e., that concentration changes in selected serum metabolites can contain sufficient information to classify rats by diet. The current study distinguished 101 (female) and 112 (male) chromatographically identifiable compounds that differ between ad libitum (AL) consumption and DR 6-mo-old rats. In a cohort of female rats, both hierarchical cluster analysis (HCA) and principal component analyses (PCA) could distinguish dietary groups with 100% efficiency (101 metabolites). Repeating the classification studies using the 63 biologically and analytically most robust metabolites decreased noise without affecting categorical separation. In a cohort of male rats, PCA, but not HCA, distinguished the original dietary groups with 100% accuracy (112 metabolites). A subset of 52 of the 112 metabolites enabled both HCA and PCA to group the male rats with 100% accuracy. These data demonstrate that quantitative analysis of selected serum metabolites can yield sufficient information by which to classify the dietary intake of a group of rats, identify such markers chromatographically and set the stage for validation of these metabolic serotypes in independent datasets.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11983833     DOI: 10.1093/jn/132.5.1031

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  7 in total

1.  Metabolomic applications of electrochemistry/mass spectrometry.

Authors:  Paul H Gamache; David F Meyer; Michael C Granger; Ian N Acworth
Journal:  J Am Soc Mass Spectrom       Date:  2004-12       Impact factor: 3.109

2.  Identification of metabolites from liquid chromatography-coulometric array detection profiling: gas chromatography-mass spectrometry and refractionation provide essential information orthogonal to LC-MS/microNMR.

Authors:  Rose M Gathungu; Susan S Bird; Diane P Sheldon; Roger Kautz; Paul Vouros; Wayne R Matson; Bruce S Kristal
Journal:  Anal Biochem       Date:  2014-03-18       Impact factor: 3.365

Review 3.  Metabolomics in the developmental origins of obesity and its cardiometabolic consequences.

Authors:  M F Hivert; W Perng; S M Watkins; C S Newgard; L C Kenny; B S Kristal; M E Patti; E Isganaitis; D L DeMeo; E Oken; M W Gillman
Journal:  J Dev Orig Health Dis       Date:  2015-01-29       Impact factor: 2.401

Review 4.  Metabolic investigation in psychiatric disorders.

Authors:  Jeffrey K Yao; Ravinder D Reddy
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

5.  Structural characterization of plasma metabolites detected via LC-electrochemical coulometric array using LC-UV fractionation, MS, and NMR.

Authors:  Susan S Bird; Diane P Sheldon; Rose M Gathungu; Paul Vouros; Roger Kautz; Wayne R Matson; Bruce S Kristal
Journal:  Anal Chem       Date:  2012-11-06       Impact factor: 6.986

6.  Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept.

Authors:  R Kaddurah-Daouk; S H Boyle; W Matson; S Sharma; S Matson; H Zhu; M B Bogdanov; E Churchill; R R Krishnan; A J Rush; E Pickering; M Delnomdedieu
Journal:  Transl Psychiatry       Date:  2011       Impact factor: 6.222

7.  Biological variability dominates and influences analytical variance in HPLC-ECD studies of the human plasma metabolome.

Authors:  Yevgeniya I Shurubor; Wayne R Matson; Walter C Willett; Susan E Hankinson; Bruce S Kristal
Journal:  BMC Clin Pathol       Date:  2007-11-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.